Faculty Information - Naoki Kashihara

Present specialized field

BooK

Journal

Presentation

Belonging society

（Last updated : 2024-04-23 14:03:23）

Naoki Kashihara
Department Kawasaki Medical School Faculty of Medicine, Kawasaki Medical School,

Position

■ Present specialized field

Nephrology, Cardiology

■ BooK

1.	2020/12/21		Blood Pressure Management in Diabetic Kidney Disease, Diabetic Kidney Disease
2.	2014/05		"Reactive Oxygen Species in the Pathogenesis of Chronic Kidney Disease: Lessons Derived from Diabetic Nephropathy ", Systems Biology of Free Radicals and Antioxidants

■ Journal

1.	2023/10/01	Insights into the regulation of glomerular filtration rate by the Keap1-Nrf2 pathway
2.	2023/07/19	eGFR slope as a surrogate endpoint for clinical study in early stage of chronic kidney disease: from The Japan Chronic Kidney Disease Database
3.	2023/07/18	Relationship between the lower limit of systolic blood pressure target and kidney function decline in advanced chronic kidney disease: an instrumental variable analysis from the REACH-J CKD cohort study
4.	2023/06	Effect of the Diabetic Nephropathy Aggravation Prevention Program on medical visit behavior in individuals under the municipal national health insurance
5.	2023/05/04	Randomized, double-blind, placebo-controlled phase 3 study of bardoxolone methyl in patients with diabetic kidney disease: design and baseline characteristics of the AYAME study
6.	2023/05	Current status of the rapid decline in renal function due to diabetes mellitus and its associated factors: analysis using the National Database of Health Checkups in Japan
7.	2023/02/09	Targeting the Alternative Complement Pathway With Iptacopan to Treat IgA Nephropathy: Design and Rationale of the APPLAUSE-IgAN Study
8.	2023/02	Genome-wide association study of the risk of chronic kidney disease and kidney-related traits in the Japanese population: J-Kidney-Biobank
9.	2023/02	The renoprotective effect of esaxerenone independent of blood pressure lowering: a post hoc mediation analysis of the ESAX-DN trial
10.	2023/01/01	A Randomized Controlled Trial of Whole-Body Vibration on Gait Ability and Balance among Older Hemodialysis Patients
11.	2023/01	Machine-learning-based Web system for the prediction of chronic kidney disease progression and mortality
12.	2022/07	Analysis of inflammatory cytokines and estimated glomerular filtration rate decline in Japanese patients with diabetic kidney disease: a pilot study.
13.	2022/04	Gross hematuria after SARS-CoV-2 vaccination: questionnaire survey in Japan.
14.	2022/03/23	A case of pleuroperitoneal communication during long-term steroid therapy for dermatomyositis
15.	2022/03	Kidney vascular congestion exacerbates acute kidney injury in mice.
16.	2022/02/24	Reduction in the magnitude of serum potassium elevation in combination therapy with esaxerenone (CS-3150) and sodium-glucose cotransporter 2 inhibitor in patients with diabetic kidney disease: Subanalysis of two phase III studies.
17.	2022/02/01	Evaluation of Neutrophil Dynamics Change by Protective Effect of Tadalafil After Renal Ischemia/Reperfusion Using In Vivo Real-time Imaging.
18.	2022/01/06	Trans-ethnic Mendelian-randomization study reveals causal relationships between cardiometabolic factors and chronic kidney disease.
19.	2022/01	Statement of the Asian Hypertension Society Network: the Okinawa Declaration on the unity of hypertension societies in Asian countries and regions to overcome hypertension and hypertension-related diseases.
20.	2021/12	Physical functioning in patients with chronic kidney disease stage G3b-5 in Japan: The reach-J CKD cohort study.
21.	2021/11	Kidney Outcomes Associated With SGLT2 Inhibitors Versus Other Glucose-Lowering Drugs in Real-world Clinical Practice: The Japan Chronic Kidney Disease Database.
22.	2021/10	Efficacy and safety of esaxerenone (CS-3150) in Japanese patients with type 2 diabetes and macroalbuminuria: a multicenter, single-arm, open-label phase III study.
23.	2021/09	Nationwide survey of the coronavirus disease 2019 prevention and treatment systems for kidney disease patients: a study of Japanese Society of Nephrology-certified educational facilities.
24.	2021/08/17	Efficacy of the Self-management Support System DialBetesPlus for Diabetic Kidney Disease: Protocol for a Randomized Controlled Trial.
25.	2021/08/02	Prologue: Special Spotlight Issue on Japan.
26.	2021/08	A rare case of amyloid light-chain amyloidosis with bilateral perirenal hematoma shortly after initiation of peritoneal dialysis.
27.	2021/08	Comparison of annual eGFR decline among primary kidney diseases in patients with CKD G3b-5: results from a REACH-J CKD cohort study.
28.	2021/08	Toward the development of a vibrant, super-aged society: The future of medicine and society in Japan.
29.	2021/06/04	Dual disruption of eNOS and ApoE gene accelerates kidney fibrosis and senescence after injury.
30.	2021/06	Renal cell carcinoma sharply captured by imaging technology at an early stage in a hemodialysis patient: Usefulness of noninvasive monochrome superb microvascular imaging
31.	2021/05/11	Effect of zinc deficiency on chronic kidney disease progression and effect modification by hypoalbuminemia.
32.	2021/05	Incidence and factors associated with prescribing renin-angiotensin-system inhibitors in adult idiopathic nephrotic syndrome: A nationwide cohort study.
33.	2021/04/23	Proteinuria changes in kidney disease patients with clinical remission during the COVID-19 pandemic.
34.	2021/04/17	SH3BP2 Deficiency Ameliorates Murine Systemic Lupus Erythematosus.
35.	2021/04/12	International Society of Nephrology Global Kidney Health Atlas: structures, organization and services for the management of kidney failure in North and East Asia.
36.	2021/01/19	Cardiovascular and Renal Outcomes Associated With Hyperkalemia in Chronic Kidney Disease: A Hospital-Based Cohort Study.
37.	2021	Infection prevention measures for patients undergoing hemodialysis during the COVID-19 pandemic in Japan: a nationwide questionnaire survey.
38.	2020/12/24	Drastic change in protein intake may cause a rapid decline of residual renal function after initiation of peritoneal dialysis.
39.	2020/12/13	Glomerular Classification Using Convolutional Neural Networks Based on Defined Annotation Criteria and Concordance Evaluation Among Clinicians.
40.	2020/12/07	Esaxerenone (CS-3150) in Patients with Type 2 Diabetes and Microalbuminuria (ESAX-DN): Phase 3 Randomized Controlled Clinical Trial.
41.	2020/12	Correction of serum potassium with sodium zirconium cyclosilicate in Japanese patients with hyperkalemia: a randomized, dose-response, phase 2/3 study.
42.	2020/12	Esaxerenone (CS-3150) in Patients with Type 2 Diabetes and Microalbuminuria (ESAX-DN): Phase 3 Randomized Controlled Clinical Trial
43.	2020/11/03	Association of Arterial Stiffness With Kidney Function Among Adults Without Chronic Kidney Disease.
44.	2020/11/01	Non-purine selective xanthine oxidase inhibitor ameliorates glomerular endothelial injury in InsAkita diabetic mice.
45.	2020/10/24	A phase 3 multicenter open-label maintenance study to investigate the long-term safety of sodium zirconium cyclosilicate in Japanese subjects with hyperkalemia.
46.	2020/10/17	Clinical and Economic　Burden of Hyperkalemia: A Nationwide Hospital-Based Cohort Study in Japan.
47.	2020/10/15	Prevalences of hyperuricemia and electrolyte abnormalities in patients with chronic kidney disease in Japan: A nationwide, cross-sectional cohort study using data from the Japan Chronic Kidney Disease Database (J-CKD-DB)
48.	2020/10/08	Dapagliflozin in Patients with Chronic Kidney Disease.
49.	2020/10	Better remission rates in elderly Japanese patients with primary membranous nephropathy in nationwide real-world practice: The Japan Nephrotic Syndrome Cohort Study (JNSCS).
50.	2020/10	The dapagliflozin and prevention of adverse outcomes in chronic kidney disease (DAPA-CKD) trial: baseline characteristics.
51.	2020/09	A nationwide cross-sectional analysis of thrombotic microangiopathy in the Japan Renal Biopsy Registry (J-RBR)
52.	2020/07/20	Prevalence of anemia in patients with chronic kidney disease in Japan: A nationwide, cross-sectional cohort study using data from the Japan Chronic Kidney Disease Database (J-CKD-DB).
53.	2020/06	Incidence of remission and relapse of proteinuria, end-stage kidney disease, mortality, and major outcomes in primary nephrotic syndrome: the Japan Nephrotic Syndrome Cohort Study (JNSCS)
54.	2020/05/29	Application of explainable ensemble artificial intelligence model to categorization of hemodialysis-patient and treatment using nationwide-real-world data in Japan.
55.	2020/05/01	Klotho is a novel therapeutic target in peritoneal fibrosis via Wnt signaling inhibition.
56.	2020/05	Dialysis Care and Dialysis Funding in Asia.
57.	2020/04/30	J-CKD-DB: a nationwide multicentre electronic health record-based chronic kidney disease database in Japan.
58.	2020/03	Conditions, pathogenesis, and progression of diabetic kidney disease and early decliner in Japan.
59.	2019/11	Bardoxolone methyl analog attenuates proteinuria-induced tubular damage by modulating mitochondrial function.
60.	2019/11	New measures against chronic kidney diseases in Japan since 2018.
61.	2019/10	JSH Statement: Asahikawa declaration in promotion of diversity by the Japanese society of hypertension-the JSH Asahikawa declaration.
62.	2019/09	The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2019).
63.	2019/07	Evaluation of Glomerular Hemodynamic Function by Empagliflozin in Diabetic Mice Using In Vivo Imaging.
64.	2019/06	JSH Statement: Kyoto declaration on hypertension research in Asia.
65.	2019/05/30	Hyperkalemia in Real-World Patients Under Continuous Medical Care in Japan.
66.	2019/05	Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial.
67.	2019/04	Sh3bp2 Gain-Of-Function Mutation Ameliorates Lupus Phenotypes in B6.MRL-Fas^lpr Mice.
68.	2019/01	5-Aminolevulinic acid exerts renoprotective effect via Nrf2 activation in murine rhabdomyolysis-induced acute kidney injury.
69.	2019/01	Essential points from Evidence-based Clinical Practice Guidelines for Chronic Kidney Disease 2018.
70.	2018/12	Guidelines for clinical evaluation of chronic kidney disease : AMED research on regulatory science of pharmaceuticals and medical devices.
71.	2018/12	Regional variations in immunosuppressive therapy in patients with primary nephrotic syndrome: the Japan nephrotic syndrome cohort study.
72.	2018/12	The Japanese Society of Hypertension-Digest of plan for the future.
73.	2018/10/03	The eNOS-NO pathway attenuates kidney dysfunction via suppression of inflammasome activation in aldosterone-induced renal injury model mice.
74.	2018/10	The Japanese clinical practice guideline for acute kidney injury 2016..
75.	2018/09	Observation period for changes in proteinuria and risk prediction of end-stage renal disease in general population.
76.	2018/08	The Japanese Clinical Practice Guideline for acute kidney injury 2016.
77.	2018/07	Disease burden and challenges of chronic kidney disease in North and East Asia.
78.	2018/04	A nationwide prospective cohort study of patients with advanced chronic kidney disease in Japan: The Reach-J CKD cohort study.
79.	2018/04	Importance of glomerular filtration rate change as surrogate endpoint for the future incidence of end-stage renal disease in general Japanese population: community-based cohort study.
80.	2018/02	The Sendai declaration for the eradication of kidney disease.
81.	2018/01	Proteinuria in neuronal intranuclear inclusion disease
82.	2017/08	Infiltration of M1, but not M2, macrophages is impaired after unilateral ureter obstruction in Nrf2-deficient mice.
83.	2017/06	Colchicine attenuates renal fibrosis in a murine unilateral ureteral obstruction model.
84.	2017/06	Restricted nutrition-induced low birth weight, low number of nephrons and glomerular mesangium injury in Japanese quail.
85.	2017/03	Acute improvement of endothelial functions after oral ingestion of isohumulones, bitter components of beer
86.	2016/12	Concurrent Lateral Meniscal Repair with Anterior Cruciate Ligament Reconstruction Induces the Extrusion of the Lateral Meniscus: Assessments of Magnetic Resonance Images.
87.	2016/10	Klotho attenuates renal hypertrophy and glomerular injury in Ins2Akita diabetic mice.
88.	2016/08	A Case of Copper Deficiency-Induced Pancytopenia With Maintenance Hemodialysis Outpatient Treated With Polaprezinc.
89.	2016/06	The Effect of Sitagliptin on Carotid Artery Atherosclerosis in Type 2 Diabetes: The PROLOGUE Randomized Controlled Trial.
90.	2016/05/23	Feasibility of fluorescence energy transfer system for imaging the renoprotective effects of aliskiren in diabetic mice.
91.	2016/02	Prevalence of gastroesophageal reflux disease symptoms and effects of esomeprazole on the quality of life related to reflux and dyspepsia in patients on maintenance hemodialysis.
92.	2016/01	Activation of endothelial NAD(P)H oxidase accelerates early glomerular injury in diabetic mice.
93.	2015/12	Severe hyperkalemia following ileostomy not colostomy in a patient undergoing chronic hemodialysis
94.	2015/09	Excess aldosterone is a critical danger signal for inflammasome activation in the development of renal fibrosis in mice.
95.	2015/09	Relationship between vascular function indexes, renal arteriolosclerosis, and renal clinical outcomes in chronic kidney disease.
96.	2015/08	Deficiency of endothelial nitric oxide signaling pathway exacerbates peritoneal fibrosis in mice.
97.	2015/05	Combination Irbesartan/Amlodipine versus Irbesartan/Cilnidipine for Attenuation of Albuminuria in Rats with Streptozotocin-Induced Diabetic Nephropathy
98.	2015/04	Massive cystic degeneration of a uterine leiomyoma in a patient with autosomal dominant polycystic kidney disease.
99.	2015/03	Differential effectiveness of ARB plus CCB therapy and high-dose ARB therapy in high-risk elderly hypertensive patients: subanalysis of the OSCAR study
100.	2014/12	Nuclear Factor Erythroid 2-Related Factor 2 is Activated by Rosuvastatin via p21cip1 Upregulation in Endothelial Cells
101.	2014/10	Combinations of olmesartan and a calcium channel blocker or a diuretic in elderly hypertensive patients: a randomized, controlled trial.
102.	2014/07	Comparison of the antialbuminuric effects of benidipine and hydrochlorothiazide in Renin-Angiotensin System (RAS) inhibitor-treated hypertensive patients with albuminuria: the COSMO-CKD (COmbination Strategy on Renal Function of Benidipine or Diuretics TreatMent with RAS inhibitOrs in a Chronic Kidney Disease Hypertensive Population) study.
103.	2014/04	The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2014).
104.	2014/02	Angiotensin II Regulates Islet Microcirculation and Insulin Secretion in Mice.
105.	2014	Hypertension promotes islet morphological changes with vascular injury on pre-diabetic status in SHRsp rats.
106.	2013/08	Guidelines on the use of iodinated contrast media in patients with kidney disease 2012: digest version : JSN, JRS, and JCS Joint Working Group.
107.	2013/08	Guidelines on the use of iodinated contrast media in patients with kidney disease 2012: digest version : JSN, JRS, and JCS Joint Working Group.
108.	2013/06	Maintenance of endothelial guanosine triphosphate cyclohydrolase I ameliorates diabetic nephropathy.
109.	2013/04	Erythropoietin-producing tubercle granuloma in a hemodialysis patient.
110.	2013/04	Japan Renal Biopsy Registry and Japan Kidney Disease Registry: Committee Report for 2009 and 2010
111.	2013/04	Selective estrogen receptor modulation attenuates proteinuria-induced renal tubular damage by modulating mitochondrial oxidative status.
112.	2013/03	Angiostatin production increases in response to decreased nitric oxide in aging rat kidney.
113.	2013/02	GFR estimation using standardized serum cystatin C in Japan
114.	2012/12	Establishment of a blood purification system for renal failure rats using small-size dialyzer membranes.
115.	2012/12	Klotho protects against mouse renal fibrosis by inhibiting Wnt signaling.
116.	2012/10	Angiotensin II receptor blocker-based therapy in Japanese elderly, high-risk, hypertensive patients.
117.	2012/08	Tacrolimus Induces Glomerular Injury via Endothelial Dysfunction Caused by Reactive Oxygen Species and Inflammatory Change.
118.	2012/06	Endothelial dysfunction promotes the transition from compensatory renal hypertrophy to kidney injury after unilateral nephrectomy in mice.
119.	2012/03	Azelnidipine attenuates glomerular damage in Dahl salt-sensitive rats by suppressing sympathetic nerve activity.
120.	2012	Chronic Kidney Disease, Dyslipidemia, and Atherosclerosis.
121.	2011/08	Design and rationale of Japanese evaluation between Formula of Azelnidipine and amlodipine add on olmesartan to Get antialbuminuric effect study (J-FLAG) : evaluation of the antialbuminuric effects between calcium channel blocker with sympatholytic action in hypertensive patients with diabetes and albuminuria.
122.	2011/04	Overexpression of klotho protein modulates uninephrectomy-induced compensatory renal hypertrophy by suppressing IGF-I signals.
123.	2011/02	Mitochondrial damage-induced impairment of angiogenesis in the aging rat kidney.
124.	2011	A novel mutation ApoE2 Kurashiki (R158P) in a patient with lipoprotein glomerulopathy.
125.	2011	Comparison of Combination Therapy of Olmesartan plus Azelnidipine or Hydrochlorothiazide on Renal and Vascular Damage in SHR/NDmcr-cp Rats.
126.	2010/12	Erythropoietin enhances hydrogen peroxide-mediated dilatation of canine coronary collateral arterioles during myocardial ischemia in dogs in vivo
127.	2010/11	Histopathological manifestations of membranoproliferative glomerulonephritis and glomerular expression of plasmalemmal vesicle-associated protein-1 in a patient with polycythemia vera
128.	2010/09	Deterioration of glomerular endothelial surface layer induced by oxidative stress is implicated in altered permeability of macromolecules in Zucker fatty rats.
129.	2010/09	Renal denervation reduces glomerular injury by suppressing NAD(P)H oxidase activity in Dahl salt-sensitive rats.
130.	2010/07	Clear Correlation of Tetrahydrobiopterin with Nitric Oxide Bioavailability in Continuous Ambulatory Peritoneal Dialysis
131.	2010/05	Involvement of the renin-angiotensin system in the development of vascular damage in a rat model of arthritis: effect of angiotensin receptor blockers.
132.	2010/02	In vivo visualization of glomerular microcirculation and hyperfiltration in streptozotocin-induced diabetic rats.
133.	2010/02	Telmisartan improves endothelial dysfunction and renal autoregulation in Dahl salt-sensitive rats
134.	2010	Oxidative stress in diabetic nephropathy.
135.	2009/12	Azelnidipine exerts renoprotective effects by improvement of renal microcirculation in angiotensin II infusion rats.
136.	2009/12	Renal protective effect of RAAS blockade across the renal continuum, with a review of the efficacy and safety of valsartan.
137.	2009/10	Tonsillectomy and steroid pulse (TSP) therapy for patients with IgA nephropathy: a nationwide survey of TSP therapy in Japan and an analysis of the predictive factors for resistance to TSP therapy.
138.	2009/09	Reactive oxygen species mediate compensatory glomerular hypertrophy in rat uninephrectomized kidney
139.	2009/06	Zinc deficiency anemia and effects of zinc therapy in maintenance hemodialysis patients.
140.	2009/05	High dietary protein intake induces endothelial dysfunction in uninephrectomized rats
141.	2009/04	C/EBP-beta modulates transcription of tubulointerstitial nephritis antigen in obstructive uropathy.
142.	2009/03	Oral adsorbent AST-120 ameliorates endothelial dysfunction independent of renal function in rats with subtotal nephrectomy
143.	2009/01	Direct Measurement of Nitric Oxide Concentration in CAPD Dialysate
144.	2008/12	Angiotensin II type 1 receptor blocker ameliorates uncoupled endothelial nitric oxide synthase in rats with experimental diabetic nephropathy
145.	2008/12	Rap1b GTPase ameliorates glucose-induced mitochondrial dysfunction
146.	2008/04	Blockade of serotonin 2A receptor improves glomerular endothelial function in rats with streptozotocin-induced diabetic nephropathy.
147.	2008/04	Pioglitazone enhances the antihypertensive and renoprotective effects of candesartan in Zucker obese rats fed a high-protein diet.
148.	2008/02	Olmesartan ameliorates progressive glomerular injury in subtotal nephrectomized rats through suppression of superoxide production.
149.	2008	Abdominal pain as the initial presentation of Takayasu arteritis.
150.	2008	Co-occurrence of poststreptococcal reactive arthritis and acute glomerulonephritis.
151.	2008	Efficacy of low-dose tacrolimus added to methotrexate in patients with rheumatoid arthritis in Japan: a retrospective study.
152.	2007/10	Olmesartan ameliorates renovascular injury and oxidative stress in Zucker obese rats enhanced by dietary protein.
153.	2007/10	Pioglitazone ameliorates endothelial dysfunction in obese rats with nephropathy.
154.	2007/06	Fluvastatin reverses endothelial dysfunction and increased vascular oxidative stress in rat adjuvant-induced arthritis.
155.	2007/03	A requirement of FANCL and FANCD2 monoubiquitination in DNA repair
156.	2007/03	Enhanced TGF-beta/Smad signaling in the early stage of diabetic nephropathy is independent of the AT1a receptor.
157.	2007/03	Transcription factor decoy oligonucleotide-based therapeutic strategy for renal disease.
158.	2007/02/20	Bilateral ureteral stenosis and duodenal perforation in a patient with dermatomyositis.
159.	2007/02	Amelioration of progressive renal injury by genetic manipulation of Klotho gene.
160.	2007/02	Isohumulones Derived from Hops Ameliorate Renal Injury via an Anti-Oxidative Effect in Dahl Salt-Sensitive Rats.
161.	2007	Anti-tumor necrosis factor therapy increases serum adiponectin levels with the improvement of endothelial dysfunction in patients with rheumatoid arthritis.
162.	2007	Enhanced TGF-b/Smad signaling in the early stage of diabetic nephropathy is independent of the AT1a receptor.
163.	2006/09	Cardioprotective role of endogenous hydrogen peroxide during ischemia-reperfusion injury in canine coronary microcirculation in vivo
164.	2006/06	Endothelial dysfunction in rat adjuvant-induced arthritis: vascular superoxide production by NAD(P)H oxidase and uncoupled endothelial nitric oxide synthase.
165.	2006/02	A nosocomial parvovirus B19 infection-induced transient aplastic crisis in a patient with chronic renal failure
166.	2006	Implication of Peritubular Capillary Loss and Altered Expression of Vascular Endothelial Growth Factor in IgA Nephropathy.
167.	2005/06	A case of Vogt-Koyanagi-Harada disease that developed relapsing polychondritis.
168.	2005/06	NAD(P)H oxidase and uncoupled nitric oxide synthase are major sources of glomerular superoxide in rats with experimental diabetic nephropathy
169.	2005	Systemic nitric oxide production rate during hemodialysis and its relationship with nitric oxide-related factors
170.	2004/06	A randomized open-label comparative study of conventional therapy versus mizoribine onlay therapy in patients with steroid-resistant nephrotic syndrome (postmarketing survey).
171.	2004/03	Overexpression of Angiotensin Type 2 Receptor Ameliorates Glomerular Injury in mouse remnant kidney model
172.	2003/07	Glomerular cell apoptosis in human lupus nephritis
173.	2003/06	A novel free radical scavenger, edarabone, protects against cisplatin-induced acute renal damage in vitro and in vivo.
174.	2003	Implication of apoptosis in progression of renal diseases
175.	2001/11	Membranous nephropathy associated with hepatitis C virus infection.
176.	2001/06	hOGG1 polymorphism correlates with progression of IgA Nephropathy
177.	2001/04	Transdominant negative FGF receptors inhibit proliferation of cultured glomerular mesangial cells.
178.	2001/02	Renal interstitial fibrosis is reduced in angiotensin II type 1a receptor-deficient mice.
179.	2001	Methylprednisolone accelerates the resolution of glomerulonephritis by sensitizing mesangial cells to apoptosis.
180.	2000/10	Expression characteristics and relevance of sodium glucose cotranspoter-1 in mammalian renal tubulogenesis.
181.	2000/09	Apoptosis and extracellular matrix-cell interactions in Kidney disease.
182.	2000/03	Lewis(y) expression and renal tubular atrophy in IgA nephritis.
183.	2000/01	Caldesmon isoform associated with phenotypic modulation of mesangial cells.
184.	2000/01	Malignant hypertension with a rare complication of pulmonary alveolar hemorrhage
185.	2000/01	Synthesis and biological activities of hapalosin derivatives with modification at the C12 position.
186.	2000	Fatal pancreatitis associated with systemic amyloidosis in a rheumatoid arthritis patient.
187.	1999/12	Role of membrane-type matrix metalloproteinase 1 (MT-1-MMP), MMP-2, and its inhibitor in nephrogenesis.
188.	1999/11	Expression of the fibroblast growth factor receptor 1-4 genes in glomeruli in anti-Thy1.1 mesangial proliferative glomerulonephritis.
189.	1999/09	Tubulointerstitial nephritis antigen: an extracellular matrix protein that selectively regulates tubulogenesis vs. glomerulogenesis during mammalian renal development.
190.	1999/08	Cloning of rat fibrillin-2 cDNA and its role in branching morphogenesis of embryonic lung
191.	1999	Mechanisms for induction of apoptosis and glomerular disease.
192.	1999	Treatment with a Ca(2+) channel blocker, barnidipine, reduces platelet-derived growth facto B-chain mRNA in glomeruli of spontaneously hypertensive rats.
193.	1998/11	Concomitant use of simvastatin and cyclosporin A increases LDH in nephrotic syndrome.
194.	1998/11	Isolation of rat fibrillar-1 cDNA and its relevance in metanephric development.
195.	1998/10	Regulation of survival and death of mesangial cells by extracellular matrix.
Display 5 items
Display all(195)

■ Presentation

1.	2021/07/19	Explainable artificial intelligence system for hemodialysis patients reveals disease background difference. （口頭）
2.	2021/04/20	Burden of Hyperkalemia in Patients with Chronic Kidney Disease: A Report from the DISCOVER CKD Retrospective Cohort （ポスター掲示）
3.	2021/04/20	Evaluating Chronic Kidney Disease Progression: A Report from the DISCOVER CKD Retrospective Cohort （ポスター掲示）
4.	2021/04/20	Treatment Patterns in Chronic Kidney Disease Patients with Hyperkalemia: A Report from the DISCOVER CKD Retrospective Cohort （ポスター掲示）
5.	2021/02/28	Development and initial analysis of a nationwide multicenter electronic health record-based chronic kidney disease database in Japan(J-CKD-DB) （口頭，特別講演・招待講演など）
6.	2021/02/28	Evaluation of glomerular hemodynamic changes by SGLT2 inhibitor and ARB in type 2 diabetic rats using in vivo imaging （口頭，一般）
7.	2020/11/07	SH3BP2 Deciency Ameliorates Murine Systemic Lupus Erythematosus （ポスター掲示，一般）
8.	2020/10/24	SH3BP2 deficiency ameliorates murine systemic lupus erythematosus （ポスター掲示，一般）
9.	2020/10/19	Effect of Zinc Deficiency on CKD Progression and Effect Modification by Hypoalbuminemia. （一般）
10.	2020/10/19	Effects of Improvements in Nutritional and Physical Conditions on Life Prognosis in Elderly Hemodialysis Patients in Japan. （一般）
11.	2020/10/19	eNOS/NO Signaling Attenuates Progression of Age-Related Kidney Diseases via Suppression of Inflammasome. （一般）
12.	2020/10/02	DEFICIENT OF ENOS/NO PATHWAY PROMOTES AKI TO CKD TRANSITION AFTER ISCHEMIC REPERFUSION （ポスター掲示，一般）
13.	2020/10/02	DISRUPTION OF DNA DAM AGE RESPONSE DRIVES TOR-AUTOPHAGY SPATIAL COUPLING COMPARTMENT (TASCC) FORMATION AND KIDNEY FIBROSIS THROUGH P53-CYCLIN G1 UPREGULATION （口頭，一般）
14.	2020/10/02	ENOS/NO SIGNALLING ATTENUATES GLOMERULAR INJURY IN DIABETIC MICE VIA SUPPRESSION OF INFLAMMASOME ACTIVATION （ポスター掲示，一般）
15.	2020/10/02	ESTABLISHMENT OF A COMPREHENSIVE NATIONWIDE BIOBANK FOR KIDNEY DISEASES WITH DEEP GENETIC DATA, DETAILED CLINICAL INFORMATION AND BIOSPECIMENS （ポスター掲示，一般）
16.	2020/10/02	EVALUATION OF THE MECHANISM OF GLOMERULAR ARTERIOLE CHANGES BY SGLT2 INHIBITION IN TYPE 2 DIABETIC RATS （ポスター掲示，一般）
17.	2020/10/02	Inflammasome Activation Plays a Key Role on the Progression of Peritoneal Fibrosis in Mice （ポスター掲示，一般）
18.	2020/10/02	THE EFFECTS OF SGLT2 INHIBITORS ON GLOMERULAR HYPERFILTRATION AND OXIDATIVE STRESS IN MICE WITH DIABETIC KIDNEY DISEASE （ポスター掲示，一般）
19.	2020/09/25	Elucidation of the pathophysiological mechanisms in diabetic kidney disease using intravital imaging. （口頭，シンポジウム・ワークショップパネル（その他））
20.	2020/06/07	Effects of sodium–glucose cotransporter 2 inhibitor, canagliflozin on glomerular hyperfiltration and oxidative stress in mice with type 2 diabetes （口頭，一般）
21.	2020/06/07	EVALUATION OF GLOMERULAR HEMODYNAMIC CHANGES BY SGLT2 INHIBITION IN TYPE 2 DIABETIC RATS USING IN VIVO IMAGING TECHNIQUES （口頭，一般）
22.	2020/06/07	KEAP1/NRF2 PATHWAY REGULATES GFR BY INCREASING THE GLOMERULAR EFFECTIVE AREA WITHOUT AFFECTING THE AFFERENT/EFFERENT ARTERIOLE RATIO （口頭）
23.	2019/11/09	Development of an Exhaustive-Risk-Prediction System Using Deep Learning and Different Patterns of Diabetic Kidney Disease Progression Based on Patient Characteristics （ポスター掲示，一般）
24.	2019/11/09	Endothelial Nitric Oxide Synthase/Nitric Oxide Pathway Underlies the Mechanisms of AKI to CKD Transition via Prolonged Activation of the Wnt/β-Catenin Pathway （ポスター掲示，一般）
25.	2019/11/08	Association of Arterial Stiffness with Kidney Function Among Adults Without CKD （ポスター掲示，一般）
26.	2019/11/08	Clarification of the Mechanism of Acute GFR Change by SGLT2 Inhibition with In Vivo Imaging Technique （ポスター掲示，一般）
27.	2019/11/07	Activation of the Keap1/Nrf2 Pathway Increases GFR by Increasing Glomerular Effective Filtration Area Without Affecting the Afferent/Efferent Arteriole Ratio （ポスター掲示，一般）
28.	2019/09/07	A Case of rapid decline of residual renal function after initiation of initiation of peritoneal dialysis. （ポスター掲示，一般）
29.	2019/09/05	Inframmasome activation plays a key role in chronic inflammation and development of peri-toneal fibrosis （ポスター掲示，一般）
30.	2019/06/13	Implication of inflammasome activation in the development of peritoneal fibrosis. （ポスター掲示，一般）
31.	2019/06/13	Investigation of the suppressive effects of an SGLT2 inhibitor on glomerular hyperfiltration and oxidative stress in mice with diabetic kidney disease. （ポスター掲示，一般）
32.	2019/06/13	Measures against chronic kidney disease in Japan. （ポスター掲示，一般）
33.	2019/04/17	SH3BP2 gain-of-function mutation ameliorates lupus in B6.MRL-Faslpr mice （口頭，一般）
34.	2019/04/12	Bardoxolone methyl analog attenuates proteinuria-induced tubular damege by modulating mitochondrial function. （ポスター掲示，一般）
35.	2019/04/12	Effect of uremic toxin-indoxcyl sulfate on intestinal defensin expression in renal failure mice. （ポスター掲示，一般）
36.	2019/04/12	Evaluation of the diabetic glomerular hemodynamics by SGLT2 inhibitor empagliflozin using in vivo imaging. （ポスター掲示，一般）
37.	2019/04/11	Pathological role of SGLT2 in diabetic kidney disease - experimental insights. （口頭，シンポジウム・ワークショップパネル（指名））
38.	2018/10/25	Annual Estimated GFR Decline in Japanese Patients with CKD G3b-5: A Result from a Japanese Nationwide Cohort Study for Patients with Advanced CKD: The Reach-J Study （抄録のみ，一般）
39.	2018/10/25	Endothelial Dysfunction Exacerbates Renal Tubular Cell Injury Through Inflammasome Activation in a Hypertensive Mouse Model （ポスター掲示，一般）
40.	2018/10/25	Nrf2 Activator, RTAdh404, Attenuates Tubular Injury via Eliminating Mitochondrial ROS in Proteinuria Induced Renal Failure Mice （ポスター掲示，一般）
41.	2018/10/25	Uremic Toxin Decreases Intestinal Defense Peptides and Barrier Functions in Chronic Renal Failure Mice （ポスター掲示，一般）
42.	2018/09/14	Control of Blood Pressure in Diabetic Hypertension （口頭，シンポジウム・ワークショップパネル（指名））
43.	2018/08/03	Utility of an instructor playing the role of patient and evaluator in Mini CEX （ポスター掲示，一般）
44.	2018/06/23	Evaluation of Glomerular Hemodynamic Function by Empagliflozin in Diabetic Mice Using In Vivo Imaging. （口頭，一般）
45.	2018/05/25	EVALUATION OF THE GLOMERULAR HEMODYNAMICS BY THE SGLT2 INHIBITOR EMPAGLIFLOZIN USING IN VIVO IMAGING （ポスター掲示，一般）
46.	2018/05/25	NRF2 ACTIVATOR, RTADH404, ATTENUATES RENAL TUBULAR INJURY VIA MITOCHONDRIAL PROTECTION IN NEPHROTIC MODEL MICE. （ポスター掲示，一般）
47.	2018/03/30	Endothelial Dysfunction and Renal Fibrosis （口頭，シンポジウム・ワークショップパネル（指名））
48.	2018/02/22	5-aminolevulinic acid exerts renoprotective effect via Nrf2 activation in rhabdomyolysis-induced acute kidney injury . （ポスター掲示，一般）
49.	2018/02/22	A case of copper deficiency-induced pancytopenia with maintenance hemodialysis outpatient treated with polaprezinc . （ポスター掲示，一般）
50.	2018/02/22	Diagnosis of a case of anti-neutrophil cytoplasmic antibody associated Glomerulonephritis during a school health examination. （ポスター掲示，一般）
51.	2018/02/22	DPP4 inhibitor linagliptin ameliorates diabetic kidneydisease through the protection of glomerular endothelial function in mice. （ポスター掲示，一般）
52.	2018/02/22	Effect of single pill-based combination therapy on variability of home blood pressure in hypertensive outpatients. （ポスター掲示，一般）
53.	2018/02/22	eNOS -NO signaling attenuates renal fibrosis via suppression of catenin signaling. （ポスター掲示，一般）
54.	2018/02/22	Evaluation of the glomerular hemodynamics alterations by SGLT2 inhibitor Empagliflozin using in vivo imaging. （ポスター掲示，一般）
55.	2018/02/22	Membranous nephropathy diagnosed in the early stages of pregnancy :A case report. （ポスター掲示，一般）
56.	2018/02/22	Non-purine selective xanthine oxidase inhibitor ameliorates glomerular endothelial injury in Ins2Akita diabetic mice. （ポスター掲示，一般）
57.	2018/02/22	RTAdh404 attenuates renal inflammation and fibrosis via mitochondrial protection in ICGN mice. （ポスター掲示，一般）
58.	2018/02/22	The association of microbiota alteration and intestinal barrier function in chronic renal failure mice. （ポスター掲示，一般）
59.	2018/02/22	The eNOS/NO signaring attenuates glomerular injury in diabetic mice via suppression of inflammasome activation. （ポスター掲示，一般）
60.	2018/02/10	Evaluation of the glomerular hemodynamics alterations by SGLT2 inhibitor Empagliflozin in diabetic mice using in vivo imaging. （ポスター掲示，一般）
61.	2017/11/07	SH3BP2 Gain-of-Function Mutation Ameliorates Lupus in B6.MRL-Faslpr Mice （ポスター掲示，一般）
62.	2017/11/03	Deficient of Endothelial Function Exacerbates NLRP3-Inflammasome Activation in Podocyte of Diabetic Nephropathy （ポスター掲示，一般）
63.	2017/11/03	Importance of eGFR Change as a Surrogate End Point of ESRD in a Randomized Controlled Trial. （ポスター掲示，一般）
64.	2017/11/02	Evaluation of the Reno-Protective Effects of Empagliflozin in Diabetic Nephropathy Using In Vivo Imaging （ポスター掲示，一般）
65.	2017/09/15	DPP4 inhibitor reduces urinary albumin excretion through the protection of glomerular endothelial function （口頭，一般）
66.	2017/09/15	Evaluation of the effect of empagliflozin on improving hyperfiltration in diabetic nephropathy （口頭，一般）
67.	2017/06/05	ENOS/NO Signaling Attenuates Glomerular Injury in Diabetic Mice via Suppression of Inflammasome Activation. （ポスター掲示，一般）
68.	2017/06/04	Endothelial Dysfunction : a common mechanism underling diabetic kidney disease. （口頭，シンポジウム・ワークショップパネル（指名））
69.	2017/06/04	Infiltaration on M1 macrophages is Impaired but not M2,After Unilateral, Ureter Obstruction in NRF2 Deficient Mice. （ポスター掲示，一般）
70.	2016/11/17	Nrf2 Dependent Inflmmasome Activation Contributes to Maintain M1 Macrophage but Not M2 Infiltration in Kidney Disease Model . （ポスター掲示，一般）
71.	2016/11/17	The DPP-4 Inhibitor Linagliptin Reduces Albuminuria Independently of Blood Glucose Levels （ポスター掲示，一般）
72.	2016/11/16	eNOS-NO Pathway Attenuates Chronic Inflammation via Nitric Oxide in Hypertensive Kidney Disease. （ポスター掲示，一般）
73.	2016/09/28	Effect of Single Pill-Based Combination Therapy of Olmesartan and Azelnidipine on Variability of Home Blood Pressure in Hypertensive Outpatients. （ポスター掲示，一般）
74.	2016/09/27	Activation of Endothelial NAD(P)H Oxidase Accelerates Early Glomerular Injury in Diabetic Mice. （ポスター掲示，一般）
75.	2016/09/26	Cyclic GMP Dependent Protein Kinase-AKT Pathway is Essential for Compensatory Renal Hypertrophy and Maintenance Renal Function After Unilateral Nephrectomy. （ポスター掲示，一般）
76.	2016/09/26	Endothelial Cells Regulate Inflammasome Activation Through Nitric Oxde in Hypertensive Kidney Disease. （ポスター掲示，一般）
77.	2016/09/26	Hypertension Promotes Islet Morphological Changes with Vascular Injury on Prediabetic Status in SHR-SP Rats. （ポスター掲示，一般）
78.	2016/09/26	Possible Implication of Xanthine Oxidase Activation on the Pathogenesis Diabetic Nephropathy. （ポスター掲示，一般）
79.	2016/09/26	Renal Denervation Protects Renal Function by Suppressing NAD(P)H Oxidase Activity in Dahl Salt-Sensitive Rats. （ポスター掲示，一般）
80.	2016/09/20	Development of a Novel Nationwide CKD Database-J-CKD-DB- （口頭，特別講演・招待講演など）
81.	2016/09/19	Renoprotective Effect of 5-Aminolevulinic Acid in Rhabdomyolysis-Induced Acute Kidney Injury （口頭，一般）
82.	2016/09/18	Effects of Lanthanum Carbonate on Intestinal Bacterial Flora and Intestinal Barrier Function in Chronic Renal Failure Mice （ポスター掲示，一般）
83.	2016/02/27	Effects of Lanthanum Carbonate on Intestinal Bacterial Flora and Intestinal Barrier Function in Chronic Renal Failure Mice （口頭，一般）
84.	2015/11/07	5-Aminolevulinic Acid Attenuates Rhabdomyolysis-Induced Acute Kidney Injury in Mice . （ポスター掲示，一般）
85.	2015/11/06	Effects of Lanthanum Carbonate on Intestinal Bacterial Flora in Chronic Renal Failure Mice. （ポスター掲示，一般）
86.	2015/11/05	Possible Implication of Xanthine Oxidase Activation on the Pathogenesis Diabetic Nephropathy. （ポスター掲示，一般）
87.	2015/09/28	Excess Aldosterone is a Critical Danger Signal for Inflammasome Activation in the Development of Renal Fibrosis in Mice. （ポスター掲示，一般）
88.	2015/09/25	Possible implication of xanthine oxidase activation on the pathogenesis diabetic nephropathy. （ポスター掲示，一般）
89.	2015/09/25	Visualization of in vivo renin activity and its application to study the pathogenetic mechanisms of diabetic nephropathy （ポスター掲示，一般）
90.	2015/07/25	The effects of pre-clinical clerkship lectures by Essential Medical Skill Ed ucation Team （口頭，一般）
91.	2015/07/24	Attempt of medical education using a high-performance simulator at Kawasaki Medical School and affiliated hospital （口頭，一般）
92.	2015/03/16	Low-Dose Colchicine Treatment Attenuates Renal Fibrosis in Mice Unilateral Ureteral Obstruction. （ポスター掲示，一般）
93.	2015/02/28	Protective role of klotho protein on peritoneal membrane via suppression of wnt/B-catenin signaling in mice. （口頭，一般）
94.	2014/11/15	In Vivo Serial Multiphoton Imaging of the Early Changes in Glomerular Structure and Function in Nephrotic NEP25/Podocin-Confetti Mice （口頭，一般）
95.	2014/11/15	Klotho Overexpression Attenuates Peritoneal Fibrosis via Suppression of Wnt/B-Catenin Signaling Pathway in Mice （口頭，一般）
96.	2014/11/14	Enhancement of Wnt/B-Catenin Signaling Promotes Renal Fibrosis by Inducing Cell Cycle Arrest at the G2/M Phase in Tubular Epithelial Cells （ポスター掲示，一般）
97.	2014/10/17	Development of a Novel In Vivo-Imaging Technique to Detect Renin-Activity in an Attempt to Elucidate Reno-Protective Effects of Calcium-Channel Blocker （ポスター掲示，一般）
98.	2014/10/17	Molecular Mechanisms of Aldosterone-Induced Renal Interstitial Fibrosis and Ameliorative Effects of Mineralocorticoid Receptor Antagonist （口頭，一般）
99.	2014/09/09	Development of a Novel Technique to Visualize in Vivo Renin Activity and Assess its Use in the Study of the Pathogenesis of Diabetic Nephropathy. （ポスター掲示，一般）
100.	2014/06/01	Activation of eNOS Signaling Attenuates Renal Fibrosis in Mice by The Increase of Beta Catenin Degradation. （ポスター掲示，一般）
101.	2014/06/01	Rosuvastatin Reduces Albuminuria in Akita Diabetic mice by p21Cip1 up-regulation Through Nuclear Factor Erythroid 2-Like Factor2 Activation. （ポスター掲示，一般）
102.	2014/06/01	The Effect of Azelnizipine on Tissue/Plasma Renin Activity in mice with Diabetic Nephropathy. （ポスター掲示，一般）
103.	2014/05/15	Benidipine Attenuates Albuminuria Through Amelioration of Enos Uncoupling in Hypertensive Kidney Disease Model. （ポスター掲示，一般）
104.	2014/05/15	Implication of Inflammasome Activation in The Development of Renal Interstitial Inflammation and Fibrosis Induced by Aldosterone. （口頭，一般）
105.	2014/04/14	Nuclear factor erythroid 2-like factor 2 activation by rosuvastatin reduces albuminuria in Akita diabetic mice （ポスター掲示，一般）
106.	2014/02/22	Aldosterone induces renal tubulointerstitial inflammation and fibrosis via activation of inflammasome in infltrating macrophages. （ポスター掲示，一般）
107.	2013/11/09	Comparison of Combination Therapy with Irbesartan/Amlodipine and Irbesartan/Cilnidipine for Attenuation of Albuminuria in Rats with Streptozotocin-Induced Diabetic Nephropathy. （ポスター掲示，一般）
108.	2013/11/09	Rosuvastatin Activates Transcription Factor Nrf2 through p21cip1 Expression and Prevents Albuminuria through Preservation of Glomerular Endothelial Integrity in AKITA Diabetic Mice. （口頭，一般）
109.	2013/11/07	Implication of Inflammasome Activation via Mitochondrial Reactive Oxygen Species in the Development of Renal Interstitial Fibrosis Induced by Aldosterone. （ポスター掲示，一般）
110.	2013/11/07	T Type Ca-Channel Blocker Exerts Anti-Albuminuic Effect through Amelioration of eNOS Uncoupling in Hypertensive Kidney Disease Model. （ポスター掲示，一般）
111.	2013/10/26	Molecular Mechanism of Mineralocorticoid Receptor Antagonist on Suppressive Effects of Inflammasome Activation by Aldosterone. （ポスター掲示，一般）
112.	2013/10/24	Comparison of Combination Therapy with Irbesartan/Amlodipine and Irbesartan/Cilnidipine for Attenuation of Albuminuria in Rats with Streptozotocin Induced Diabetic Nephropathy. （ポスター掲示，一般）
113.	2013/10/24	Investigation for the Mechanisms of Anti-albuminuic Effects of T Type Ca-channel Blocker through Amelioration of eNOS Uncoupling. （口頭，一般）
114.	2013/10/24	Islet Microangiopathy in Hypertensive Rats and the Protective Effects of ARB on the Islet Morphology. （口頭，一般）
115.	2013/06/02	Implications of Inflammasome-Activation in Macrophage on the Development of Renal Interstitial Inflammation and Fibrosis in Mice. （ポスター掲示，一般）
116.	2013/06/01	Development of Novel Technique to Visualize in vivo Renin Activity and Analysis of Reno-Protective Actions of Renin Inhibitor in Diabetic Nephropathy. （ポスター掲示，一般）
117.	2013/06/01	Klotho Protein Ameliorates Peritoneal Fibrosis Though The Regulation of Wnt/B-Catenin Signaling. （ポスター掲示，一般）
118.	2013/06/01	Rosuvastatin Maintain Glomerular Endothelial Surface layer Through Nrf2 Activation in Mouse Diabetic Nephropathy. （ポスター掲示，一般）
119.	2013/04/28	Aldosterone induces renal interstitial inflammation and fibrosis by activation of inflammasome via mitochondrial reactive oxygen species in macrophage. （ポスター掲示，一般）
120.	2013/04/24	Enhanced apoptosis may lead to fewer nephrons in Japanese quail subjected to reduced nutrition during development. （ポスター掲示，一般）
121.	2013/04/21	Implication of inflammasome in the development of renal interstitial fibrosis induced by aldsoterone （ポスター掲示，一般）
122.	2012/12/06	Unmet Clinical Needs in Managing Hypertension Imprinted Memories in Our Organs. （口頭，特別講演・招待講演など）
123.	2012/11/07	Preservation of Endothelial GTP Cyclohydrolase I Activity and Improvement of Renal Nitric Oxide Availability Prevent the Development of Albuminuria in Diabetes （ポスター掲示，一般）
124.	2012/11/06	Spironolactone Suppresses the Inflammasome in Aldosterone Induced Renal Dysfunction via Blood Pressure Independent Pathway. （ポスター掲示，一般）
125.	2012/11/03	Rosuvastatin Activates Transcription Factor Nrf2 and Protects Prevents Albuminuria through Preservation of the Glomerular Endothelial Integrity in Akita Diabetic Mice. （ポスター掲示，一般）
126.	2012/11/02	Erythropoietin Activates NAD(P)H Oxidase via Erythropoietin Receptor and Beta Common Receptor on Vascular Endothelial Cells. （ポスター掲示，一般）
127.	2012/11/02	Klotho Attenuates Inflammation of Adipose Tissue and Development of Insulin Resistance in High-Fat Induced Obese Mice. （ポスター掲示，一般）
128.	2012/11/02	Overexpression of the Klotho Protein Attenuates Peritoneal Fibrosis by Suppressing Wnt-Signaling. （ポスター掲示，一般）
129.	2012/11/02	Stimulation of Soluble Guanylate Cyclase Attenuates Epithelial-Mesenchymal Transition of the Peritoneal Membrane and Prevent the Development of Peritoneal Fibrosis. （口頭，一般）
130.	2012/11/01	Development of a Novel Technique to Visualize In Vivo Renin Activity and Analysis of the Renoprotective Actions of a Renin Inhibitor. （ポスター掲示，一般）
131.	2012/09/07	Oxidativ stress,tissue ischemia and deterioration of renal microcirculation elucidated with in vivo imaging technique,in the pathogenesis of chronic kidney disease. （口頭，シンポジウム・ワークショップパネル（その他））
132.	2012/07/20	eNOS-sGC pathway suppresses renal fibrosis via interruption of the Wnt-beta-catenin pathway in UUO mice. （ポスター掲示，一般）
133.	2012/05/26	Raloxifene Ameliorates Proteinuria-Induced Inflammasome Activation and Tubular Injury. （ポスター掲示，一般）
134.	2012/05/25	Endothelial Cell Interacted with Podocyte and Mesangial Cells Via NAD(P)H Oxidase. （ポスター掲示，一般）
135.	2012/05/25	Endothelial Dysfunction promotes the Transition from Compensatory Renal Hypertrophy to Kidney Injury after Unilateral Neophrectomy in Mice. （ポスター掲示）
136.	2012/05/25	Preservation of Endothelial GTP Cyclohydrolase I Activity and Improvement of Renal Nitric Oxide Availability Prevent the Development of Diabetic Nephropathy （ポスター掲示，一般）
137.	2011/11/30	The Glycocalyx （口頭，特別講演・招待講演など）
138.	2011/11/12	Low-Dose Erythropoietin Increases Superoxide Production in Normal Rat Aorta and Endothelial Cells （ポスター掲示，一般）
139.	2011/11/12	Selective Estrogen Receptor Modulator Inhibits Fatty Acid-Induced Inflammasome Activation and Attenuates Proteinuria-Induced Tubular Injury in Mice （ポスター掲示，一般）
140.	2011/11/11	Implications of Oxidative Stress Derived from Endothelial NAD(P)H Oxdase in the Development of Diabetic Nephropathy （ポスター掲示，一般）
141.	2011/11/10	Mouse Renal Fibrosis after Unilateral Ureteral Obstruction Is Reduced by Klotho Protein Overexpression through Wnt Signaling Inhibition （ポスター掲示，一般）
142.	2011/11/10	Preservation of Endothelial GTP Cyclohydrolase I Activity by Metformin Prevent the Development of Diabetic Nephropathy （ポスター掲示，一般）
143.	2011/09/22	Endothelial NAD(P)H oxidase activation enhance urinary albumin excretion and progress renal dysfunction in mouse type 1 diabetic nephropathy. （ポスター掲示，一般）
144.	2011/09/22	Role of GTP cyclohydrolase-1 as a novel therapeutic target of diabetic nephropathy. （ポスター掲示，一般）
145.	2011/07/30	Role of Endothelial Dysfunction in The Development of Albuminuria （口頭，シンポジウム・ワークショップパネル（その他））
146.	2011/07/16	Comparison of combination therapy of olmesartan plus azelnidipine or hydrochlorothiazide on renal and vascular damage in SHR/NDmcr-cp rats. （ポスター掲示，一般）
147.	2011/05/12	Effect of selective estrogen receptor modulator in renal proximal tubles. （ポスター掲示，一般）
148.	2011/04/11	Selective Estrogen Receptor Modulator Ameriorate Proteinuria Induced Tubular Damage by Reducing Oxidative Mitochondrial Stress. （ポスター掲示，一般）
149.	2011/04/10	Cyclic GMP Dependent Protein Kinase-Akt Pathway is Essential for Compensatory Renal Hypertrophy and Maintenance Renal Function After Unilateral Nephrectomy. （ポスター掲示，一般）
150.	2011/04/10	Over-Expression of Endothelial GTP Cyclohydrolase-ⅠAmeliorates Mouse　Diabetic Glomerulopathy. （ポスター掲示，一般）
151.	2010/12/02	Renoprotective benefits of RAS inhibition:focus on prevention and treatment of chronic kidney disease. （口頭，シンポジウム・ワークショップパネル（その他））
152.	2010/11/20	Selective Estrogen Receptor Modulator Attenuates Alubumin-Induced Apoptosis in Renal Proximal Tubules through Inhibition ob Mitochondrial Stress （ポスター掲示，一般）
153.	2010/11/19	Nitric Oxide Induces Tubular Cell Hypertrophy Via Cyclic GMP-Dependedent Protein Kinase in Rat Compensatory Renal Hypertrophy （ポスター掲示，一般）
154.	2010/11/18	Over-Expression of GTP Cyclohydrolase-ⅠRetards Development of Albuminuria and Ameliorates Renal Injuries in Diabetes （ポスター掲示，一般）
155.	2010/11/16	Cardioprotective Role of Hydrogen Peroxide and Erythropoietin during Acute Coronary Occlusion in Canine Native Coronary Collateral Microcirculation in Vivo （ポスター掲示，一般）
156.	2010/09/26	Cardioprotective Effects of Hydrogen Peroxide after Erythropoietin Administration during Acute Coronary Occlusion in Canine Native Coronary Collateral Microcirculation in Vivo （ポスター掲示，一般）
157.	2010/09/26	Eplerenone improved renal and vascular injuries in Zucker obese rats fed high-protein diet （ポスター掲示，一般）
158.	2010/09/26	Nitric oxide induces tubular cell hypertrophy via cyclic GMP-dependent protein kinase in rat compensatory renal hypertrophy. （ポスター掲示，一般）
159.	2010/06/27	Mechanisms of acute tacrolims-induced nephrotoxicity and the renoprotective effects of telmisartan （ポスター掲示，一般）
160.	2010/06/26	Calcium channel blokers azelnidipine but not amlodipine reduce glomerular damages in Dahl salt -sansitive rats by suppression of sympathetic nerve system （ポスター掲示，一般）
161.	2010/06/26	Establishment of new blood purification system in renal failure rats using a small dialyzer （ポスター掲示，一般）
162.	2010/06/26	Renal denervation reduces glomerular superoxide production and protects from gromerular injury in Dahl salt-sensitive rats （ポスター掲示，一般）
163.	2010/06/15	Renal denervation attenuates glomerular schrelosis by suppressing NAD(P)H oxidase activity in Dahl salt-sensitive rats （ポスター掲示，一般）
164.	2010/05/15	Effects of eplerenone to renal and vascular injuries in Zucker obese rats fed high-protein diet （ポスター掲示，一般）
165.	2010/04/17	ARB/CCB combination therapy suppressed oxidative stress compared with ARB/HCTZ combination therapy in glomeruli and aorta of metabolic syndrome model rats （ポスター掲示，一般）
166.	2010/04/17	Glomerular endothelial glycocalyx was decreases by reactive oxygen species in Zucker obese fatty rat （ポスター掲示，一般）
167.	2010/04/17	Klotho overexpression attenuates renal fibrosis after unilateral obstruction by Wnt signaling inhibition （口頭，特別講演・招待講演など）
168.	2010/04/16	Renal denervation protects from glomerular injyury by suppressing NAD(P)H oxidase activity in Dahl salt-sensitive rats （ポスター掲示，一般）
169.	2010/03/05	Deterioration of Glomerular Endothelial Glycocalyx Induced by Heparanase is Imvolved in Cardio-Renal Interaction （ポスター掲示，一般）
170.	2009/11/14	Cardioprotective effects of hydrogen peroxide and erythropoietin during acute coronary occlusion in canine coronary native collateral microvessels in vivo （ポスター掲示，一般）
171.	2009/10/31	Renal Denervation Protects Renal Function by Suppressing NAD(P)H Oxidase Activity in Dahl Salt-Sensitive Rats （ポスター掲示，一般）
172.	2009/10/30	Azelnidipine Prevents Renal Dysfunction by Suppression of Sympathetic Nerve System in Dahl Salt-Sensitive Rats （ポスター掲示，一般）
173.	2009/10/30	Deterioration of Glomerular Endothelial Glycocalyx Induced by Oxidative Stress is Implicated in Altered Permeability of Macromolecules in Zucker Obese Fatty Rat （ポスター掲示，一般）
174.	2009/10/30	DNA Methylation Modulates the Transcription of TubuloInterstitial Nephritis Antigen in Lewis Rats （口頭，一般）
175.	2009/10/30	Increased Angiostatin Production by Nitric Oxide Reduction Induces Tubulointerstitial Damage in Rat Aging Kidney （ポスター掲示，一般）
176.	2009/10/29	Alpha-Klotho Attenuates Renal Fibrosis after Unilateral Ureteral Obstruction through Inhibition of Wnt Signaling （ポスター掲示，一般）
177.	2009/10/29	Comparison of the Renal and Vascular Protective Effects of Olmesartan/Azelnidipine with Olmesartan/Hydrochlorothiazide Combination Therapy in Metabolic Syndrome Model Rats （ポスター掲示，一般）
178.	2009/10/29	Development of Novel Blood Purification System in Rats （ポスター掲示，一般）
179.	2009/10/29	Overexpression of Klotho Protein Inhibits Uninephrectmy Induced Compensatory renal Hypertrophy by Suppressing Insulin Like Growth Factor-1 Signals （口頭，一般）
180.	2009/10/29	Renoprotective Effects of Azelnidipine by Improvements of renal Microcirculation in Angiotensin ll infusion Rat. （ポスター掲示，一般）
181.	2009/07/17	Bezafibrate ameliorates endotthelial dysfunction in Zucker fatty rats fed high pyotein diet （ポスター掲示）
182.	2009/07/17	Cilostazol improved high dietary protein-induced endothelial dysfunction in uninephrectomized rats （ポスター掲示，一般）
183.	2009/07/17	Low dose eplerenone ameliorated glomerulosclerosis and endothelial dysfunction through antioxidative stress in metabolic syndrome model rats （ポスター掲示）
184.	2009/06/12	Role of renin-angiotensin system activation in the development of vascular damages in rat adjuvant-induced arthritis: effect of angiotensin receptor blockers （ポスター掲示，一般）
185.	2009/02/21	Renal protection by anti-DM/HTN drugs （口頭）
186.	2008/11/07	Implication of endothelial dysfunction and micro-hemodynamic changes in the pathogenesis of chronic kidney disease （口頭，特別講演・招待講演など）
187.	2008/11/06	Oral adsorbent AST-120 ameliorates endothelial dysfunction and alleviates oxidative stress in aorta independent of renal function in subtotally nephrectomized rats （ポスター掲示，一般）
188.	2008/09/23	Systemic inflammation in rat arthritis model potentiates hypertensive and vascular hypertrophic responses to angiotensin II
189.	2008/02/28	Effects of high-volume or high-flow continuous renal replacement therapy and PMX-DHP for patients with septic shock （ポスター掲示，一般）
190.	2007/11/22	Direct Measurement of Nitric Oxide and Tetrahydrobiopterin Levels in Peritoneal Dialysate （ポスター掲示，一般）
191.	2007/10/31	Angiotensin Receptor Blocker Ameliorates Dietary Protein Induced Renovasucular Injury and Oxidative Stress in Zucker Obese Rats. （ポスター掲示，一般）
192.	2007/10/31	Compensatory Kidney Growth after Rat Nephrectomy Requier Superoxide Via NADPH Oxidase （ポスター掲示，一般）
193.	2007/10/31	Direct Measurement of Nitric Oxide Levels in Peritoneal Dialysate. （ポスター掲示，一般）
194.	2007/10/31	In VivoVisualization of Glomerular Hyperfiltration and Microcircuration in STZ-Induced Diabetic Rats. （ポスター掲示，一般）
195.	2007/04/26	Fluvastatin reverses endothelial dysfunction and increased vascular oxidative stress in rat adjuvant-induced arthritis （口頭，シンポジウム・ワークショップパネル（その他））
196.	2006/11/14	Pioglitazone Ameliorates Endothelial and Renal Injuries through an Anti-Oxidative Effect in Zucker Obese Rats on a High-Protein Diet. （ポスター掲示，一般）
197.	2006/11/14	Possible Mechanism in Improvement of Progressive Renal Injuries in Klotho Over-Expressing ICGN Mice （ポスター掲示，一般）
198.	2006/11/14	Suppression of Oxidative Stress by Combination Therapy with a Statin and an ACE Inhibitor STZ-Induced Diabetic Rat. （ポスター掲示，一般）
199.	2006/11/14	Therapeutic Effect Pitavastatin on Renal Injury Induced by Hypertension （ポスター掲示，一般）
200.	2006/10/20	NAD(P)H oxidase and Uncoupled Nitric Oxide Synthase are Major Sources of Superoxide in Hypertensive and Diabetic Rat Kidney （ポスター掲示，一般）
201.	2006/10/15	Direct Method to Detect Reactive Oxygen Species (ROS) and Nitric Oxide (NO) in Kidney of Hypertensive Rats
202.	2006/10/15	Hops-derived Isohumulones Ameliorate Renal Injury through Anti-oxidative Effect in Dahl Salt-Sensitive Rats （ポスター掲示，一般）
203.	2006/10/15	Relation of Endothelial Dysfunction in Rheumatoid Arthritis to Adiponection Level
204.	2006/10/15	Role of Reactive Oxygen Species (ROS) and Nitric Oxide (NO) in Hypertrophy in Kidney after Uninephrectomy
205.	2006/10/15	Therapeutic Effect of Pitavastatin on Renal Injury Induced by Hypertension
206.	2006/10	Sarpogrelate Hydrochloride Inhibits Reactive Oxygen Species (ROS) Production in Diabetic Nephropathy （ポスター掲示）
207.	2006/08/25	A Study of Tailored Nutrition Support for Peritoneal Dialysis Patients （ポスター掲示）
208.	2006/08/25	Direct Measurement of Effluent Nitric Oxide Levels in CAPD Patients （ポスター掲示）
209.	2005/11/12	Infliximab Improves Serum Adiponectin Levels and Endothelial Dysfunction in Patients with Rheumatoid Arthritis （ポスター掲示，一般）
210.	2005/11/08	Implication of Senescence Associated Klotho Gene in the Pathogenesis of Progressive Renal Injuries. （口頭，一般）
211.	2005/11/08	Isohumulones Derived from Hops Ameliorate Renal Injury with Anti-Oxidative and Anti-Hypertensive Effects in Dahl Salt-Sensitive Hypertensive Rats. （ポスター掲示，一般）
212.	2005/11/08	Mitochondrial Dysfunction Impairs Up-Regulation of Vascular Endothelial Growth Factor Expression in the Aging Kidney. （ポスター掲示，一般）
213.	2005/11/08	Role of Reactive Oxygen Species (ROS) and Nitric Oxide (NO) in Hypertrophy in the Kidney after Uninephrectomy. （ポスター掲示，一般）
214.	2005/04/24	Estimated nitric oxide production rate in hemodialysis
215.	2004/10/27	Abnormalities in Renal Autoregulation Due to Imbalance Reactive Oxygen Species and Nitric Oxide. （ポスター掲示，一般）
216.	2004/10/27	Losartan Improves the Imbalance between Nitric Oxide and Reactive Oxygen Species in the Diabetic Nephropathy （ポスター掲示，一般）
217.	2004/10/27	The Role of Abnormal Iron Metabolism in the Development of Oxidative Peritoneal Injury （ポスター掲示，一般）
218.	2003/11/12	A Long Acting Calcium Channel Blocker, Azelnidipine, Ameliorates Angiotensin II Induced Renal Damage in Rats. （ポスター掲示，一般）
219.	2003/11/12	Calcium Channel Blocker and Angiotensin Redceptor Blocker Improve Tubulointerstitial Hypoxia and Prevent Progress of Tubular Damage in the Dahl Salt Sensitive rat Kidney （ポスター掲示，一般）
220.	2003/11/12	Imbalance of Nitric Oxide and Reactive Oxygen species Contributes to the Progression of Renal Damage in Rat 5/6 Remmnant Model （ポスター掲示，一般）
221.	2003/11/12	In situ Detection of Nitric Oxide in the Rat Kidney Using the Fluorescent Dye, Diaminorhodamine （ポスター掲示，一般）
222.	2003/11/12	NAD(P)H Oxidase and Uncoupled Nitric Oxide Synthase Are Major Sources of Superoxide in the Rat Experimental Diabetic Nephropathy （ポスター掲示，一般）
223.	2003/11/12	Progranulin (PC-Cell-Derived Growth Factor) Expression in the Kidney of Various Rat Renal Disease Models （ポスター掲示，一般）
224.	2003/11/12	The Implications of NO and ROS Their Interaction in the Pathogenesis of Peritoneal Injury （ポスター掲示，一般）
225.	2003/06/08	continuous hemodialysis improves the mortality of critical patients with acute renal failure in comparison with continuous hemofiltration
226.	2002/11/02	Novel Free Radical Scavenger, MCI-186,Protects Cisplatin-Induced Acute Renal Damage In Vitro and In Vivo. （ポスター掲示，一般）
227.	2002/11/01	Impaird Angiogenesis in the Development on Interstitial Fibrosis in the Progressive Renal Diseases. （ポスター掲示，一般）
228.	2002/11/01	the Role of Angiotensin II in yhe Genoeration of Oxidative Stress in Progressive Renal Diseases:Effects of ACEI and ARB. （ポスター掲示，一般）
Display 5 items
Display all(228)

■ Belonging society

2008

∟ organizing committee member